✉ info@chemsp.cn☎ +86-18553102138 ☎ 0531-84992235
📞 WhatsApp中文
Home › Product Catalog › Bosutinib

Bosutinib

CAS 380843-75-4C26H29Cl2N5O3MW 530.4

Bosutinib (CAS 380843-75-4) — formula C26H29Cl2N5O3, molecular weight 530.4; category pharmaceutical intermediates and APIs.

Product Description

Bosutinib (CAS 380843-75-4) is a chemical raw material in the pharmaceutical intermediates and APIs category. Its molecular formula C26H29Cl2N5O3 comprises 26 C, 29 H, 2 Cl, 5 N, 3 O atoms. Its molecular weight is about 530.4. Reported physicochemical data: melting point around 131, LogP about 3.34. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.

Product Overview

CAS Number380843-75-4
Molecular FormulaC26H29Cl2N5O3
Molecular Weight530.4
Melting Point131
LogP3.34
CategoryPharmaceutical Intermediates & APIs

Technical Profile

What this product is

Bosutinib is a pharmaceutical intermediate or API compound with CAS registry number 380843-75-4 and molecular formula C26H29Cl2N5O3 (molecular weight 530.4), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.

Identification

CAS number: 380843-75-4

Its molecular formula C26H29Cl2N5O3 comprises 26 C, 29 H, 2 Cl, 5 N, 3 O atoms.

Also known as: Bosutinib · 博舒替尼

Category: pharmaceutical intermediates and APIs

Frequently Asked Questions

What is the CAS number of Bosutinib?

The CAS registry number of Bosutinib is 380843-75-4.

What is the molecular formula and molecular weight of Bosutinib?

Molecular formula C26H29Cl2N5O3, molecular weight 530.4.

What other names is Bosutinib known by?

It is also registered under: Bosutinib, 博舒替尼.

Which category does Bosutinib belong to?

Category: Pharmaceutical Intermediates & APIs.

Packaging & documentation

Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.

PubChem Public Data

Independent reference data for Bosutinib (CAS 380843-75-4), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number380843-75-4
PubChem CID5328940
Molecular formulaC26H29Cl2N5O3
IUPAC name4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
UNII (FDA)5018V4AEZ0

Computed descriptors

Molecular Weight530.4
XLogP35.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass529.1647452
Monoisotopic Mass529.1647452
Topological Polar Surface Area82.9
Heavy Atom Count36

Physicochemical values on record

Melting Point131
LogP3.34

Documented uses on record

    Bosutinib is indicated for the treatment of adult and pediatric patients 1 year of age and older with chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy. It is also indicated for the treatment of adult patients with accelerated or blast phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.Bosutinib is a dual kinase inhibitor of both the BCR-ABL and Src tyrosine kinases and is used in the therapy of Philadelphia chromosome-positive chronic myelogenous leukemia. Bosutinib therapy is associated with transient elevations in serum aminotransferase and bilirubin levels and rare instances of clinically apparent acute liver injury.

    Synonyms and trade names

    Bosutinib; 380843-75-4; SKI-606; SKI 606; 5018V4AEZ0; SK-606; CHEBI:39112; DTXSID10861568; bosutinibum; uglysycpd2; RefChem:58901; DTXCID40207910; L01XE14; 4-Anilinobenzo(g)quinoline-3-carbonitrile; 700-455-1; 943-866-3

    GHS hazard classification

    Reported hazard statementsH317 (41.7%), H319 (59.7%), H413 (55.6%)

    H317 (41.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]

    H319 (59.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

    What the public record says

    Bosutinib · CAS 380843-75-4 · C26H29Cl2N5O3. UNII 5018V4AEZ0. Melting Point: 131; LogP: 3.34.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@chemsp.cn☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 博舒替尼

Shenghe Chemical|ChemSP
鲁ICP备19037000号-2